Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 studyEzra E.W. Cohen, Signe Friesland, Douglas R. Adkins et al.|The Lancet|2018Cited by 1.7k
Pharmacokinetic evaluation of gemcitabine and 2′,2′-difluorodeoxycytidine-5′-triphosphate after prolonged infusion in patients affected by different solid tumorsLuigi Cattel, Fulvia Pedani, Mario Airoldi et al.|Annals of Oncology|2006Cited by 45
Gemcitabine and Oxaliplatin in Patients With Metastatic Breast Cancer Resistant to or Pretreated With Both Anthracyclines and TaxanesMario Airoldi, C. Micari, Luigi Cattel et al.|American Journal of Clinical Oncology|2006Cited by 17
Gemcitabine and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results.Mario Airoldi, P. Gabriele, Luigi Cattel et al.|PubMed|2003Cited by 14
Gemcitabine and Oxaliplatin in Patients With Pancreatic AdenocarcinomaMario Airoldi, Claudio Zanon, Luigi Cattel et al.|Pancreas|2005Cited by 12